Cetirizine | cetirizine tablets 10 mg 10 pcs.

Latin name

Ceretec

Release form

Film-coated tablets.

Packing

10 tablets.

Pharmacological action

Cetirizine is a competitive histamine antagonist, a metabolite of hydroxyzine, blocks H1-histamine receptors. It prevents the development and facilitates the course of allergic reactions, has an antipruritic and antiexudative effect. It affects the early stage of allergic reactions, limits the release of inflammatory mediators in the late stage of an allergic reaction, reduces the migration of eosinophils, neutrophils and basophils. Reduces capillary permeability, prevents the development of tissue edema, relieves spasm of smooth muscles.

strangers the skin reaction to the administration of histamine, specific allergens, as well as to cooling (with cold urticaria).

Virtually no anticholinergic and antiserotonin effects. In therapeutic doses, it practically does not cause a sedative effect. The onset of action after a single dose of 10 mg of cetirizine - after 20 minutes (in 50% of patients) and after 60 minutes (in 95% of patients), lasts more than 24 hours. Against the background of the course of treatment, tolerance to the antihistamine action of cetirizine does not develop. After discontinuation of treatment, the effect lasts up to 3 days.

Pharmacokinetics

Quickly absorbed from the gastrointestinal tract, the time to reach Cmax after oral administration is 1 hour. Food does not affect the completeness of absorption (AUC), but prolongs the time to reach Cmax by 1 h and reduces the value of Cmax by 23%. When taken at a dose of 10 mg 1 time / day for 10 days, the equilibrium plasma concentration is 310 ng / ml and is observed 0.5-1.5 hours after administration. Communication with plasma proteins is 93% and does not change at a concentration of cetirizine in the range of 25-1000 ng / ml. The pharmacokinetic parameters of cetirizine change linearly when administered at a dose of 5-60 mg. Vd - 0.5 l / kg. In small amounts, it is metabolized in the liver by O-dealkylation to form a pharmacologically inactive metabolite (unlike other blockers of H1-histamine receptors metabolized in the liver by the P450 cytochrome system). Does not cumulate. 2/3 of the drug is excreted unchanged by the kidneys and about 10% through the intestines.

Systemic clearance - 53 ml / minute. T1 / 2 in adults - 7-10 hours, in children 6-12 years - 6 hours, in children 2-6 years - 5 hours, in children from 6 months to 2 years - 3 hours. In elderly patients, T1 / 2 increases by 50%, systemic clearance decreases by 40% (decreased renal function).

In patients with impaired renal function (creatinine clearance below 40 ml / min), the clearance of the drug decreases, and T1 / 2 lengthens (so, in patients on hemodialysis, the total clearance decreases by 70% and is 0.3 ml / min / kg, and T1 / 2 lengthens 3 times), which requires a corresponding change in the dosage regimen.

In patients with chronic liver diseases (hepatocellular, cholestatic, or biliary cirrhosis), a T1 / 2 elongation of 50% and a decrease in overall clearance by 40% are observed (correction of the dosage regimen is required only with a concomitant decrease in glomerular filtration rate). Penetrates into breast milk.

Indications

seasonal and perennial allergic rhinitis and conjunctivitis (itching, sneezing, rhinorrhea, lacrimation, hyperemia of the conjunctiva)

urticaria (including chronic idiopathic urticaria)

itchy allergic dermatoses.

Contraindications

decreased kidney function (creatinine clearance 30-49 ml / min)

chronic renal failure

children under 6 years of age

pregnancy

lactation

hypersensitivity to cetirizine, other component.

Precautions: advanced age (possibly reduced glomerular filtration).

Use during pregnancy and lactation

Contraindicated during pregnancy and lactation.

Composition

1 film-coated tablet contains:

active substance:

cetirizine dihydrochloride 10 mg

excipients:

microcrystalline cellulose,

lactose monohydrate,

crospovidone,

magnesium stearate,

silicon dioxide colloidal.

shell composition:

[hypromellose, talc, titanium dioxide, macrogol 4000] or [dry white film shell containing hypromellose, talc, titanium dioxide, macrogol 4000].

Dosage and administration

Inside, tablets are washed down with 200 ml of water, the drops are dissolved in water before use.

Adults and children over 6 years old - 10 mg once a day or 5 mg 2 times a day,

children 2-6 years old - 5 mg 1 time a day or 2.5 mg 2 times a day, children 1-2 years old 2.5 mg (5 cap) 2 times a day.

In patients with reduced renal function (CC 30-49 ml / min), 5 mg / day is prescribed, with severe chronic renal failure (CC 10-30 ml / min) - 5 mg / day every other day.

Side effects

The drug cetirizine is usually well tolerated. Side effects occur rarely and are transient in nature.

From the digestive system: dry mouth, dyspepsia.

From the nervous system: dizziness, headache, drowsiness, fatigue, agitation, migraine.

Allergic reactions: angioedema, skin rashes, itching, urticaria.

Drug Interaction

Co-administration with theophylline (400 mg / day) leads to a decrease in total clearance of cetirizine (theophylline kinetics do not change).

Myelotoxic drugs increase the hematotoxicity of the drug.

No clinically relevant interactions with other drugs (pseudoephedrine, cimetidine, ketoconazole, erythromycin, azithromycin, diazepam, glipizide).

overdose

Symptoms: once a single dose of more than 50 mg may be accompanied by signs of intoxication in the form of drowsiness, anxiety and irritability, there may be signs of anticholinergic action in the form of urinary retention, dry mouth, constipation.

Treatment: induce vomiting, wash stomach, receive activated charcoal, seek medical advice immediately.

There is no specific antidote. Hemodialysis is ineffective.

Storage conditions

In the dark place at a temperature of 2-25 РC.

Expiration

2 years.

Deystvuyuschee substances

Cetirizine



pharmacy terms and conditions without a prescription

dosage form

dosage form

tablets

Vertex Russia Russia